RecruitingNCT07288710

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

A Prospective Observational Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy


Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Enrollment

300 participants

Start Date

Mar 9, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing how quickly patients recover from two types of lung cancer surgery — sublobar resection (removing a small portion of the lung) versus lobectomy (removing an entire lung lobe) — using wearable devices and smartphone apps to track recovery at home after surgery. **You may be eligible if...** - You are 18 or older - You are scheduled to have video-assisted thoracoscopic surgery (VATS) for lung cancer between March and December 2023 - Your overall health is good to fair (ASA grade III or below) - You have a smartphone and are willing to use a wearable device **You may NOT be eligible if...** - You are under 18 - You cannot or will not comply with using digital tracking devices - You do not have a smartphone - Your cancer has spread to lymph nodes or distant organs - Your digital device data during hospitalization was incomplete Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07288710


Related Trials